Tyler C Miller

Dr. Tyler C Miller

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
TMTyler C Miller
Tyler C Miller
CPCristina Pastuch
Cristina Pastuch
LGLisa Garavaglia
Lisa Garavaglia
KGKelley Gannon
Kelley Gannon
APAnthony Parravani
Anthony Parravani
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. Within this case, we report a 57-year-old cystic fibrosis patient with chronic kidney disease (CKD) Stage G3b (baseline 1.5–1.6 mg/dL) who developed an acute kidney injury (AKI) with a serum creatinine elevation to 4.08 mg/dL and associated worsening vestibular dysfunction related to twice-daily nebulized tobramycin inhalation solution (TIS). The patient was found to have a tobramycin serum level of 4.2 μg/mL 2.5 h after TIS dosing, with elevation remaining present at 1.1 μg/mL 24 h after discontinuation of therapy. Laboratory values at one month continued to show elevated creatinine levels at 2.1 mg/dL, suggesting progression of his baseline CKD. This case supports the benefit of obtaining tobramycin serum levels and vestibular/audiology function testing when evaluating patients on chronic nebulized TIS who present with acute or chronic renal dysfunction. From these serum levels, adjustments to daily dosing, regular monitoring of tobramycin serum levels, or discontinuation of treatment should be made to prevent permanent renal damage in patients with CKD. Calculated Naranjo ADR Probability Scale: 9; Definite.

3 August 2023 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
TMTyler C Miller
Tyler C Miller
DHDavid Hana
David Hana
BPBansari Patel
Bansari Patel
JCJustin Conte
Justin Conte
DVDhivya Velu
Dhivya Velu
Yasmin S HamiraniYasmin S Hamirani
Yasmin S Hamirani

4 July 2025 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
TMTyler C Miller
Tyler C Miller
EHEmily Hendricks
Emily Hendricks
SBSeher Berzingi
Seher Berzingi
HWHelen Watson
Helen Watson
SMSamuel Mensah
Samuel Mensah
JMJames D. Mills
James D. Mills


25 June 2025 in JACC: Case Reports
Verified
Journal Article
Open access
TMTyler C Miller
Tyler C Miller
SWStanley Wolfe
Stanley Wolfe
DSDawn Smith
Dawn Smith
JBJonathan Bond
Jonathan Bond
RHRuby Havistin
Ruby Havistin
LMLakshmi Muthukumar
Lakshmi Muthukumar
A sinus of Valsalva aneurysm (SoVA) is a rare cardiac condition caused by the dilation of a coronary sinus. If untreated, it can commonly lead to valvular dysfunction, arrhythmias, or rupture. A 71-year-old patient with hypertension and hyperlipidemia presented with an embolic stroke. Multimodality imaging revealed a large, 7.0 cm × 5.6 cm SoVA originating from the noncoronary sinus and causing nearly complete obstruction of the left atrium. The aneurysm was surgically repaired, and the patient made a full recovery. In rare cases, a stroke may be the initial presentation of a SoVA. The probable cause of the patient's stroke was attributed to thrombus formation within the SoVA that embolized. This case emphasizes the importance of multimodality imaging for the diagnosis of a SoVA and for planning surgical repair. Additionally, clinicians should consider a SoVA in the differential diagnosis for a patient presenting with a stroke.